Respiro Diagnostics Limited

DataGardener
live
Unknown

Respiro Diagnostics Limited

16447745•Private Limited With Share Capital

York Hub, Popeshead Court Offices, York, YO18SU

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

13/05/2025

Company Age

1 years

Directors

3

Employees

—

SIC Code

86900

Risk

moderate risk

Company Overview

Registration, classification & business activity

Respiro Diagnostics Limited (16447745) is a private limited with share capital incorporated on 13/05/2025 (1 years old) and registered in york, YO18SU. The company operates under SIC code 86900 - other human health activities.

Private Limited With Share Capital
SIC: 86900
Unknown
Incorporated 13/05/2025
YO18SU

Financial Overview

Total Assets

£0

Liabilities

£0

Net Assets

£0

Cash

£0

Key Metrics

3

Directors

11

Shareholders

Board of Directors

3
T
theo issitt
director
A
alison quinn
director
N
natalie pankova
director

Filed Documents

13
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:14-10-2026
Confirmation Statement With Updates
Category:Confirmation Statement
Date:21-05-2026
Capital Allotment Shares
Category:Capital
Date:20-05-2026
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-05-2026
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-05-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:20-05-2026
Capital Allotment Shares
Category:Capital
Date:11-05-2026
Memorandum Articles
Category:Incorporation
Date:20-04-2026
Resolution
Category:Resolution
Date:20-04-2026
Capital Allotment Shares
Category:Capital
Date:13-04-2026
Capital Allotment Shares
Category:Capital
Date:23-03-2026
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:29-08-2025
Incorporation Company
Category:Incorporation
Date:13-05-2025

Innovate Grants

2

This company received a grant of £219668.0 for Nhs Trialsed Liquid Biopsy For Lung Cancer: Device Optimisation For Nhs Trials. The project started on 01/07/2026 and ended on 31/12/2027.

This company received a grant of £73500.0 for Breath-Based Lung Cancer Diagnostics: Clinical Validation And Commercial Readiness. The project started on 01/07/2026 and ended on 30/06/2027.

Risk Assessment

moderate risk

International Score

Accounts

Typenot available
Due Date13/02/2027
Filing Date—
Latest Accounts—

Trading Addresses

York Hub, Popeshead Court Offices, York, Yo1 8Su, YO18SURegistered

Related Companies

7
shift.ms
live
serenatis bio limited
live
signacor therapeutics limited
live
novai ltd
live
cellestial health ltd
live
microsol ltd
live
hospice of st. francis (berkhamsted) limited
live

Contact

York Hub, Popeshead Court Offices, York, YO18SU